How is ‘higher for longer’ reshaping strategies?
Despite optimism that inflation would swiftly retreat, the latest numbers tell a different story. So what does this mean for investors?
Despite optimism that inflation would swiftly retreat, the latest numbers tell a different story. So what does this mean for investors?
PAM’s work at the KT East lithium prospect in Thailand has increased the anomalous zone by 2.8x to 2.1km long and 1km wide.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new copper project acquisition in Chile from Pan Asia Metals.
New copper supply is needed ASAP and Chile’s nimbler junior copper plays could be better placed than majors to bridge the gap.
Clinical stage biotech targeting human neurodegenerative diseases PharmAust has rebranded to Neurizon Therapeutics.
Good morning, and welcome to Stockhead’s Top 10 at 11, a short, sharp update to help frame the trading day.
Euroz’ Michael Scantlebury says Newmont’s exit at Telfer will lead to more Paterson Province M&A, with Antipa in the box seat.
These AI-powered tools enable investors to trade smart and fast.
True to its history of reinvention and repurposing, PharmAust is set to be renamed Neurizon Therapeutics as it continues its MND drug development quest.
Bitcoin jumps more than 5% after China’s lacklustre stimulus, while Nvidia climbs 2.5% as it nears record highs.
Cancer cell therapy house Chimeric Therapeutics is going to the well for a much-needed capital raising to fund its clinical programs. Read more in our health wrap.
Did you know silver has an important role to play in the world’s energy transition? Tune in to this special video conference to learn more.
Stockhead’s Top 10 at 11: a short, sharp update to help frame the trading day.
The buffet isn’t closed just yet, with host Tony Locantro still serving up some piping hot biotech dishes. Hope you saved room for seconds.
Original URL: https://www.ntnews.com.au/business/stockhead/page/197